StockData
Vaxcyte, Inc. logo

Vaxcyte, Inc. (PCVX) stock

PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$61.61−1.76 (-2.78%)

Close on Nov 16, 2026Market cap $9.17BP/E –Yield 0.00%

Vaxcyte pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Vaxcyte

Vaxcyte has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vaxcyte figures

See a number that looks wrong?